Soumen Das, Retina Paul, Utpal De, Mrityunjay Mukherjee
{"title":"乳腺癌的疫苗管理:事实或虚构。","authors":"Soumen Das, Retina Paul, Utpal De, Mrityunjay Mukherjee","doi":"10.5915/44-1-9055","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer (BC) is the most common malignancy (75-80%) among women. Options for management of BC are multivariate. Available modalities include surgery, radiotherapy, chemotherapy and hormone therapy. Despite availability of improved therapeutic adjuncts, mortality from BC is 40%. Vaccination strategies against BC are emerging as a viable alternative. This review highlights the available results of this emerging therapeutic strategy. </p>","PeriodicalId":89859,"journal":{"name":"The Journal of IMA","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2013-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/62/59/jima-44-1-09055.PMC3708638.pdf","citationCount":"0","resultStr":"{\"title\":\"Management of breast cancer by vaccine: fact or fiction.\",\"authors\":\"Soumen Das, Retina Paul, Utpal De, Mrityunjay Mukherjee\",\"doi\":\"10.5915/44-1-9055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Breast cancer (BC) is the most common malignancy (75-80%) among women. Options for management of BC are multivariate. Available modalities include surgery, radiotherapy, chemotherapy and hormone therapy. Despite availability of improved therapeutic adjuncts, mortality from BC is 40%. Vaccination strategies against BC are emerging as a viable alternative. This review highlights the available results of this emerging therapeutic strategy. </p>\",\"PeriodicalId\":89859,\"journal\":{\"name\":\"The Journal of IMA\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/62/59/jima-44-1-09055.PMC3708638.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of IMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5915/44-1-9055\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/1/1 0:00:00\",\"PubModel\":\"Print\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of IMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5915/44-1-9055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/1/1 0:00:00","PubModel":"Print","JCR":"","JCRName":"","Score":null,"Total":0}
Management of breast cancer by vaccine: fact or fiction.
Breast cancer (BC) is the most common malignancy (75-80%) among women. Options for management of BC are multivariate. Available modalities include surgery, radiotherapy, chemotherapy and hormone therapy. Despite availability of improved therapeutic adjuncts, mortality from BC is 40%. Vaccination strategies against BC are emerging as a viable alternative. This review highlights the available results of this emerging therapeutic strategy.